Tags

Type your tag names separated by a space and hit enter

The newer fluoroquinolones.
Infect Dis Clin North Am. 2009 Dec; 23(4):1027-51, x.ID

Abstract

Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin.

Authors+Show Affiliations

Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, 645 N. Michigan Avenue, Suite 900, Chicago, IL 60611, USA. m-bolon@northwestern.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

19909896

Citation

Bolon, Maureen K.. "The Newer Fluoroquinolones." Infectious Disease Clinics of North America, vol. 23, no. 4, 2009, pp. 1027-51, x.
Bolon MK. The newer fluoroquinolones. Infect Dis Clin North Am. 2009;23(4):1027-51, x.
Bolon, M. K. (2009). The newer fluoroquinolones. Infectious Disease Clinics of North America, 23(4), 1027-51, x. https://doi.org/10.1016/j.idc.2009.06.003
Bolon MK. The Newer Fluoroquinolones. Infect Dis Clin North Am. 2009;23(4):1027-51, x. PubMed PMID: 19909896.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The newer fluoroquinolones. A1 - Bolon,Maureen K, PY - 2009/11/14/entrez PY - 2009/11/17/pubmed PY - 2010/2/24/medline SP - 1027-51, x JF - Infectious disease clinics of North America JO - Infect Dis Clin North Am VL - 23 IS - 4 N2 - Clinicians have enthusiastically used fluoroquinolones owing to their good safety profile and wide range of indications. This article reviews fluoroquinolone pharmacology, pharmacodynamic principles, and fluoroquinolone resistance mechanisms, highlighting recent trends in the epidemiology of fluoroquinolone resistance among gram-negative organisms and Streptococcus pneumonia. Important fluoroquinolone safety concerns are discussed, along with indications for the most commonly used fluoroquinolones-ciprofloxacin, levofloxacin, and moxifloxacin. SN - 1557-9824 UR - https://www.unboundmedicine.com/medline/citation/19909896/The_newer_fluoroquinolones_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0891-5520(09)00048-8 DB - PRIME DP - Unbound Medicine ER -